{"url_path":"/sec/cosm/8-k/2026-07-16/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1474167/0001477932-26-004357-index.html","accession_number":"0001477932-26-004357","cik":"0001474167","ticker":"COSM","issuer_name":"Cosmos Health Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1474167/0001477932-26-004357-index.html","primary_entity_key":"0001474167","primary_entity_name":"Cosmos Health Inc."},"word_count":155,"has_tables":true,"body_markdown":"**ITEM 5.03. AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.**\n\n \n\nAs described under Item 5.07 of this Current Report on Form 8-K, at the Company’s 2026 Annual Meeting, the stockholders of the Company approved the proposed issuance and designation of one hundred thousand (100,000) shares of Series B Preferred Stock of the Company. The material terms of Series B Preferred Stock are described in detail under “Proposal 4: Approval of Designation and Issuance of Series B Preferred Stock,” commencing on page 32 of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on June 2, 2026, in connection with the Annual Meeting. The Company will file a certificate of designation with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of Series B Preferred Stock, the form of which is attached hereto as Exhibit A."}